home / stock / entbf / entbf news

ENTBF News and Press, Entheon Biomedical Corp Com From 04/05/22

Stock Information
Company Name: Entheon Biomedical Corp Com
Stock Symbol: ENTBF
Market: OTC
Website: entheonbiomedical.com
Menu
ENTBF ENTBF Quote ENTBF Short ENTBF News ENTBF Articles ENTBF Message Board
Get ENTBF Alerts

News, Short Squeeze, Breakout and More Instantly...
ENTBF - Entheon Biomedical Announces Non-Brokered Private Placement Financing

Vancouver, British Columbia--(Newsfile Corp. - April 5, 2022) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ( "Entheon" or the "Company" ), a biomedical company focused on the research and development of psychedelic drugs and leading-edge biomarkers to provide personalize...
ENTBF - Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel & New Clinical Research Platform

Improved Genetic Screening Platform to Strengthen Entheon's Psychedelic-Assisted Protocols Vancouver, British Columbia--(Newsfile Corp. - March 29, 2022) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ( "Entheon" or the "Company" ), a biomedical company focused on the res...

ENTBF - Entheon Biomedical begins enrollment in phase 1 study of DMT for addiction disorders

Entheon Biomedical (OTCQB:ENTBF) said the first patient was enrolled in a phase 1 trial called EBRX-101 evaluating N, N-dimethyltryptamine (DMT) for addiction disorders. In the study — which is being conducted at the Centre for Human Drug Research in Leiden, The Netherlands ȁ...

ENTBF - Entheon Biomedical Announces Enrollment in Phase 1 Study of DMT

Vancouver, British Columbia--(Newsfile Corp. - March 15, 2022) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (" Entheon " or the " Company "), a biomedical company focused on the research and development of psychedelic drugs and leading-edge biomarkers to provide personaliz...
ENTBF - Entheon Biomedical Announces EBIQ-101 First-Patient Dose

Vancouver, British Columbia--(Newsfile Corp. - February 24, 2022) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (" Entheon " or the " Company "), a biomedical company focused on the research and development of psychedelic drugs and leading-edge biomarkers to provide persona...

ENTBF - Entheon Biomedical Partners with Wavepaths on Upcoming Observational Study

Vancouver, British Columbia--(Newsfile Corp. - February 16, 2022) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (" Entheon " or the " Company "), a company focused on the research and development of psychedelic drugs and leading-edge biomarkers to provide personalized treat...

ENTBF - Entheon Biomedical Announces the Approval of DMT Clinical Trial

Vancouver, British Columbia--(Newsfile Corp. - February 3, 2022) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (" Entheon " or the " Company "), a biomedical company focused on the research and development of psychedelic drugs and leading-edge biomarkers to provide personal...
ENTBF - Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Psychedelics Today

Expanding brand awareness and access to HaluGen's Psychedelics Genetic Test Kit Vancouver, British Columbia--(Newsfile Corp. - January 18, 2022) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (" Entheon " or the " Company "), a biomedical company focused on the research and...

ENTBF - Entheon Biomedical Corp. Files Preliminary Shelf Prospectus

Vancouver, British Columbia--(Newsfile Corp. - January 18, 2022) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (" Entheon " or the " Company ") announced that it has filed a preliminary short form base shelf prospectus dated January 14, 2022 (the " Preliminary Prospectus ...

ENTBF - Entheon Biomedical Provides Update on DMT Human Trial and Announces Regulatory Submission to Ethics Committee

Vancouver, British Columbia--(Newsfile Corp. - January 6, 2022) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (" Entheon " or the " Company "), a biomedical company focused on the research and development of psychedelic drugs and leading-edge biomarkers to provide personali...
Previous 10 Next 10